Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6′)/APH(2″)

[1]  S. Ōmura,et al.  Biverlactones A–D, new circumventors of arbekacin resistance in MRSA, produced by Penicillium sp. FKI-4429 , 2011 .

[2]  M. Nakajima,et al.  Trends of Arbekacin-resistant MRSA Strains in Japanese Hospitals (1979 to 2000) , 2006, The Journal of Antibiotics.

[3]  Clinical,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .

[4]  J. Ishikawa,et al.  Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance. , 2004, The Journal of antibiotics.

[5]  M. Araake,et al.  [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)]. , 2003, The Japanese journal of antibiotics.

[6]  T. Udou.  [Functional characterization of a multiple-antibiotic resistant plasmid from clinical isolates of methicillin-resistant Staphylococcus aureus]. , 2001, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[7]  K. Hotta,et al.  Double stage activity in aminoglycoside antibiotics. , 2000, The Journal of antibiotics.

[8]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[9]  K. Hotta,et al.  Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications , 1999, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[10]  T. Furumai,et al.  Eurystatins A and B, new prolyl endopeptidase inhibitors. III. Fermentation and controlled biosynthesis of eurystatin analogs by Streptomyces eurythermus. , 1994, The Journal of antibiotics.

[11]  Y. Nagamachi,et al.  [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus]. , 1994, The Japanese journal of antibiotics.

[12]  A. Tomasz,et al.  Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. , 1994, The New England journal of medicine.

[13]  S. Mitsuhashi,et al.  Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus. , 1993, The Journal of antibiotics.

[14]  T. Niijima.  [New antimicrobial agent series XL: arbekacin]. , 1991, The Japanese journal of antibiotics.

[15]  B. Ganguli,et al.  Aranorosin, a novel antibiotic from Pseudoarachniotus roseus. I. Taxonomy, fermentation, isolation, chemical and biological properties. , 1988, The Journal of antibiotics.

[16]  H. Umezawa,et al.  SYNTHESES OF (S)-4-AMINO-2-HYDROXYBUTYRYL DERIVATIVES OF 3', 4'-DIDEOXYKANAMYCIN B AND THEIR ANTIBACTERIAL ACTIVITIES , 1973 .

[17]  H. Umezawa,et al.  Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria. , 1973, The Journal of antibiotics.